The Conserved Molecular Mechanism of Erectile Dysfunction in Type 2 Diabetes Rats and Mice by Cross-species Transcriptomic Comparisons

Overview

Journal Sex Med

Publisher Oxford University Press

Date 2025 Mar 5

PMID 40041301

Authors

Ming Xiao

Huanqing Zeng

Yanghua Xu

Jiarong Xu

Xiaoli Tan

Yuxin Tang

Affiliations

Soon will be listed here.

Abstract

Background: The poor clinical situation of type 2 diabetes-induced erectile dysfunction (T2DMED) creates an urgent need for new therapeutic targets.

Aim: To reveal the conserved molecular mechanism of T2DMED across species.

Methods: T2DMED rat and mouse models were constructed to extract mRNA from corpus cavernosum for high-throughput sequencing. The differentially expressed genes (DEGs) were analyzed and the Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), and Protein-Protein Interaction Networks were performed by bioinformatics methods. Immunohistochemistry, immunofluorescence, hematoxylin- eosin and Masson staining were used for subsequent verification.

Outcomes: Cross-species transcriptomics of T2DMED rats and mice were analyzed and validated.

Results: Gene expression patterns in normal corpus cavernosum of mice and rats showed a strong correlation (r = 0.75, < 2.2 × 10), with a total of 15 691 homologous genes identified. In both species, 553 homologous down-regulated DEGs were identified, mainly enriched in pathways related to smooth muscle and mitochondrial functions, as revealed by KEGG and GO analyses. Immunohistochemistry and immunofluorescence confirmed the decreased expression of α-smooth muscle actin and in cavernosum tissues of T2DMED mice and rats. Additionally, 239 homologous up-regulated DEGs were identified, which were enriched in the signaling pathway and extracellular matrix composition. Subsequent experiments confirmed increased β-catenin expression and significant collagen accumulation, indicating fibrosis in T2DMED.

Clinical Implications: To provide a new direction for improving the erectile ability of patients with T2DMED.

Strengths And Limitations: The main strength is that cross-species transcriptomic sequencing has revealed the conserved molecular mechanisms of T2DMED. The main limitation is the lack of further validation in the T2DMED patients.

Conclusions: Cross-species transcriptomic comparisons may offer a novel strategy for uncovering the underlying mechanisms and identifying therapeutic targets for T2DMED.

References

Abdelmoez A, Sardon Puig L, Smith J, Gabriel B, Savikj M, Dollet L . Comparative profiling of skeletal muscle models reveals heterogeneity of transcriptome and metabolism. Am J Physiol Cell Physiol. 2019; 318(3):C615-C626. PMC: 7099524. DOI: 10.1152/ajpcell.00540.2019. View

Yeo H, Shin M, Yoo K, Jung B, Eum W, Choi S . Tat-CIAPIN1 Prevents Pancreatic β-Cell Death in hIAPP-Induced RINm5F Cells and T2DM Animal Model. Int J Mol Sci. 2023; 24(13). PMC: 10342139. DOI: 10.3390/ijms241310478. View

Qi Y, Chen Z, Guo B, Liu Z, Wang L, Liu S . Speckle-tracking echocardiography provides sensitive measurements of subtle early alterations associated with cardiac dysfunction in T2DM rats. BMC Cardiovasc Disord. 2023; 23(1):266. PMC: 10201756. DOI: 10.1186/s12872-023-03239-2. View

Gerstein M, Rozowsky J, Yan K, Wang D, Cheng C, Brown J . Comparative analysis of the transcriptome across distant species. Nature. 2014; 512(7515):445-8. PMC: 4155737. DOI: 10.1038/nature13424. View

Huang Z, Chen Y, Zhang Y . Mitochondrial reactive oxygen species cause major oxidative mitochondrial DNA damages and repair pathways. J Biosci. 2020; 45. View

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

Humphrey J, Dufresne E, Schwartz M . Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol. 2014; 15(12):802-12. PMC: 4513363. DOI: 10.1038/nrm3896. View

Su G, Morris J, Demchak B, Bader G . Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 2014; 47:8.13.1-24. PMC: 4174321. DOI: 10.1002/0471250953.bi0813s47. View

Zhang L, Piao S, Choi M, Shin H, Jin H, Kim W . Role of increased penile expression of transforming growth factor-beta1 and activation of the Smad signaling pathway in erectile dysfunction in streptozotocin-induced diabetic rats. J Sex Med. 2008; 5(10):2318-29. DOI: 10.1111/j.1743-6109.2008.00977.x. View

10.

Shin S, Kim W, Choi M, Park J, Jin H, Yin G . Aberrant expression of Wnt family contributes to the pathogenesis of diabetes-induced erectile dysfunction. Andrology. 2013; 2(1):107-16. DOI: 10.1111/j.2047-2927.2013.00162.x. View

11.

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

12.

Hedlund P, Aszodi A, Pfeifer A, Alm P, Hofmann F, Ahmad M . Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice. Proc Natl Acad Sci U S A. 2000; 97(5):2349-54. PMC: 15804. DOI: 10.1073/pnas.030419997. View

13.

Gatti A, Mandosi E, Fallarino M, Radicioni A, Morini E, Maiani F . Metabolic syndrome and erectile dysfunction among obese non-diabetic subjects. J Endocrinol Invest. 2009; 32(6):542-5. DOI: 10.1007/BF03346504. View

14.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View

15.

Martignoni M, Groothuis G, de Kanter R . Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2006; 2(6):875-94. DOI: 10.1517/17425255.2.6.875. View

16.

Ye K, Li Z, Yin Y, Zhou J, Li D, Gan Y . LIPUS-SCs-Exo promotes peripheral nerve regeneration in cavernous nerve crush injury-induced ED rats via PI3K/Akt/FoxO signaling pathway. CNS Neurosci Ther. 2023; 29(11):3239-3258. PMC: 10580359. DOI: 10.1111/cns.14256. View

17.

Rath S, Sharma R, Gupta R, Ast T, Chan C, Durham T . MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2020; 49(D1):D1541-D1547. PMC: 7778944. DOI: 10.1093/nar/gkaa1011. View

18.

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

19.

Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov J . Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011; 27(12):1739-40. PMC: 3106198. DOI: 10.1093/bioinformatics/btr260. View

20.

Suomalainen A, Nunnari J . Mitochondria at the crossroads of health and disease. Cell. 2024; 187(11):2601-2627. DOI: 10.1016/j.cell.2024.04.037. View